VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,955 | +165.9% | 557 | +110.2% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | -14.3% | 265 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $7,000 | -30.0% | 265 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | +11.1% | 265 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $9,000 | +12.5% | 265 | +1.5% | 0.00% | 0.0% |
| Q3 2021 | $8,000 | -11.1% | 261 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | +12.5% | 261 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $8,000 | 0.0% | 261 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | +100.0% | 261 | +161.0% | 0.00% | – |
| Q2 2020 | $4,000 | -93.5% | 100 | -95.3% | 0.00% | -100.0% |
| Q4 2019 | $62,000 | +1450.0% | 2,110 | +955.0% | 0.01% | +600.0% |
| Q2 2017 | $4,000 | -20.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $5,000 | +25.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $4,000 | -20.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $5,000 | -16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $6,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |